Clinical Trial Update: Anti-VEGF vs. Prompt Vitrectomy for VH From PDR [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial comparing anti-VEGF therapy to prompt vitrectomy for vitreous hemorrhage due to proliferative diabetic retinopathy has completed with posted res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy
• Vitreous Hemorrhage

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Proliferative Diabetic Retinopathy, Vitreous Hemorrhage | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-01-19